Stockscreener 앱 받기
5.13
0.79%
0.04
시장 영업 전:
5.17
0.04
+0.78%
전일 마감가:
$5.09
열려 있는:
$5.09
하루 거래량:
935.58K
Relative Volume:
0.79
시가총액:
$244.19M
수익:
$234.96M
순이익/손실:
$-4.30M
주가수익비율:
-25.80
EPS:
-0.1988
순현금흐름:
$-1.24M
1주 성능:
+12.75%
1개월 성능:
+46.15%
6개월 성능:
-8.88%
1년 성능:
-31.96%
1일 변동 폭
$4.92
$5.22
1주일 범위
$4.31
$5.29
52주 변동 폭
$2.56
$15.84
Lifemd Inc Stock (LFMD) Company Profile
명칭
Lifemd Inc
전화
(866) 351-5907
주소
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
5.13 | 244.19M | 234.96M | -4.30M | -1.24M | -0.1988 |
VEEV
Veeva Systems Inc
|
171.19 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-16 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-06-18 | 재확인 | BTIG Research | Buy |
| 2024-12-10 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-23 | 재개 | B. Riley Securities | Buy |
| 2024-06-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | 개시 | Craig Hallum | Buy |
| 2023-07-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-03-10 | 개시 | Colliers Securities | Buy |
| 2021-10-04 | 재개 | B. Riley Securities | Buy |
모두보기
Lifemd Inc 주식(LFMD)의 최신 뉴스
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care - Yahoo Finance
LifeMD Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research - MarketBeat
LFMD Reiterated by BTIG -- Price Target Maintained at $10.00 - GuruFocus
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations - Yahoo Finance
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its earnings report after the market closes on May 6. - Moomoo
Earnings Preview: LifeMD to Report Financial Results Post-market on May 06 - Moomoo
Board revises equity incentives, enforces clawback in LifeMD (NASDAQ: LFMD) proxy - Stock Titan
LifeMD (LFMD) soars 23.7%: Is further upside left in the stock? - MSN
LFMD Technical Analysis & Stock Price Forecast - Intellectia AI
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
LifeMD to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LFMD (LifeMD Inc.) shares rise nearly four percent after Q4 2025 earnings narrowly miss analyst consensus estimates. - Cổng thông tin điện tử Tỉnh Sơn La
Amazon GLP-1 Program Pressures Hims & Hers Stock - Sahm
LifeMD (LFMD) Stock: Complete Guide (+3.53%) 2026-04-22Safe Entry Stocks - UBND thành phố Hải Phòng
Analysts Expect Breakeven For LifeMD, Inc. (NASDAQ:LFMD) Before Long - Moomoo
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock? - Yahoo Finance
LifeMD (LFMD) Stock: Resistance Rejection Signals (Momentum Building) 2026-04-20Crowd Sentiment Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Is LifeMD (LFMD) stock testing breakout levels (Overhead Buying) 2026-04-18Continuation Signals - Xã Vĩnh Công
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations - Yahoo Finance
JPMorgan Chase & Co. Has $414,000 Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - TradingView
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
LifeMD adds Eli Lilly’s oral weight loss drug to platform By Investing.com - Investing.com Canada
LifeMD adds Eli Lilly’s oral weight loss drug to platform - Investing.com
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - ChartMill
Dividend Watch: How sensitive is LifeMD Inc to inflation2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
LifeMD (NASDAQ:LFMD) Trading Down 4.2%What's Next? - MarketBeat
Big Money Moves: Why is LifeMD Inc stock going up2026 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LifeMD, Inc. (LFMD) Stock Analysis: Exploring A Potential 181.34% Upside In Telehealth - DirectorsTalk Interviews
LifeMD Earnings Call Highlights Aggressive Growth Push - TipRanks
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - Investing.com South Africa
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - bitget.com
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk - Investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - marketscreener.com
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - Seeking Alpha
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Lifemd Inc (LFMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.66%
1.60%
자본화:
|
볼륨(24시간):